12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Galderma, Nuvo sales and marketing update

Nuvo Research disclosed in its 4Q12 earnings that partner Galderma launched Pliaglis lidocaine/tetracaine in the U.S. in March to produce local anesthesia on intact skin in adults prior...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >